Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichi Tamura

Showing results (91-100 of 155) with videos related to

Pageof 16
Sort By:
Heliyon|May 30, 2023
Cardiovascular events after the initiation of immune checkpoint inhibitorsYuta Suzuki, Hidehiro Kaneko, Yuichi Tamura, et al.
Advances in Therapy|December 27, 2025
Artificial Intelligence Software for Detecting Paroxysmal Atrial Fibrillation from Sinus Rhythm Monitor ECG: Development and Clinical TrialYuichi Tamura, Tomohiro Takata, Hirohisa Taniguchi, et al.
Heart and Vessels|September 15, 2021
Comparison of left ventricular pacing performance among pre-shaped guidewires designed for transfemoral-approach transcatheter aortic valve implantationYudai Tamura, Yuichi Tamura, Yutaka Konami, et al.
JACC. Asia|November 7, 2022
Changes in the Characteristics and Initial Treatments of Pulmonary Hypertension Between 2008 and 2020 in JapanYuichi Tamura, Hiraku Kumamaru, Takumi Inami, et al.
Virology|September 2, 2006
A fused gene of nucleoprotein (NP) and herpes simplex virus genes (VP22) induces highly protective immunity against different subtypes of influenza virusSukumar Saha, Shinsuke Yoshida, Kenji Ohba, et al.
The American Journal of Cardiology|December 6, 2014
Significance of echocardiographic assessment for right ventricular function after balloon pulmonary angioplasty in patients with chronic thromboembolic induced pulmonary hypertensionToshimitsu Tsugu, Mitsushige Murata, Takashi Kawakami, et al.
Pharmaceuticals (Basel, Switzerland)|May 25, 2024
Switching from Beraprost to Selexipag in the Treatment of Pulmonary Arterial Hypertension: Insights from a Phase IV Study of the Japanese Registry (The EXCEL Study: EXChange from bEraprost to seLexipag Study)Yuichi Tamura, Hiraku Kumamaru, Ichizo Tsujino, et al.
Cardiovascular Research|December 10, 2015
Neural crest-derived resident cardiac cells contribute to the restoration of adrenergic function of transplanted heart in rodentYuichi Tamura, Motoaki Sano, Hiroshi Nakamura, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 3, 2014
Encapsulation of beraprost sodium in nanoparticles: analysis of sustained release properties, targeting abilities and pharmacological activities in animal models of pulmonary arterial hypertensionTomoaki Ishihara, Erika Hayashi, Shuhei Yamamoto, et al.
The European Respiratory Journal|December 15, 2018
Risk stratification and medical therapy of pulmonary arterial hypertensionNazzareno Galiè, Richard N Channick, Robert P Frantz, et al.
Pageof 16

Showing results (91-100 of 155) with videos related to

Sort By:
Pageof 16
Heliyon|May 30, 2023
Cardiovascular events after the initiation of immune checkpoint inhibitorsYuta Suzuki, Hidehiro Kaneko, Yuichi Tamura, et al.
Advances in Therapy|December 27, 2025
Artificial Intelligence Software for Detecting Paroxysmal Atrial Fibrillation from Sinus Rhythm Monitor ECG: Development and Clinical TrialYuichi Tamura, Tomohiro Takata, Hirohisa Taniguchi, et al.
Heart and Vessels|September 15, 2021
Comparison of left ventricular pacing performance among pre-shaped guidewires designed for transfemoral-approach transcatheter aortic valve implantationYudai Tamura, Yuichi Tamura, Yutaka Konami, et al.
JACC. Asia|November 7, 2022
Changes in the Characteristics and Initial Treatments of Pulmonary Hypertension Between 2008 and 2020 in JapanYuichi Tamura, Hiraku Kumamaru, Takumi Inami, et al.
Virology|September 2, 2006
A fused gene of nucleoprotein (NP) and herpes simplex virus genes (VP22) induces highly protective immunity against different subtypes of influenza virusSukumar Saha, Shinsuke Yoshida, Kenji Ohba, et al.
The American Journal of Cardiology|December 6, 2014
Significance of echocardiographic assessment for right ventricular function after balloon pulmonary angioplasty in patients with chronic thromboembolic induced pulmonary hypertensionToshimitsu Tsugu, Mitsushige Murata, Takashi Kawakami, et al.
Pharmaceuticals (Basel, Switzerland)|May 25, 2024
Switching from Beraprost to Selexipag in the Treatment of Pulmonary Arterial Hypertension: Insights from a Phase IV Study of the Japanese Registry (The EXCEL Study: EXChange from bEraprost to seLexipag Study)Yuichi Tamura, Hiraku Kumamaru, Ichizo Tsujino, et al.
Cardiovascular Research|December 10, 2015
Neural crest-derived resident cardiac cells contribute to the restoration of adrenergic function of transplanted heart in rodentYuichi Tamura, Motoaki Sano, Hiroshi Nakamura, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|December 3, 2014
Encapsulation of beraprost sodium in nanoparticles: analysis of sustained release properties, targeting abilities and pharmacological activities in animal models of pulmonary arterial hypertensionTomoaki Ishihara, Erika Hayashi, Shuhei Yamamoto, et al.
The European Respiratory Journal|December 15, 2018
Risk stratification and medical therapy of pulmonary arterial hypertensionNazzareno Galiè, Richard N Channick, Robert P Frantz, et al.
Pageof 16